A significant breakthrough in cancer study is occurring with the use of mini-antibodies to re-engage mutated p53. This essential tumor inhibitor protein is frequently disabled in several kinds of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research